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Abstract
Background: Healthcare access and resources differ considerably between urban and rural settings making cross-
setting generalizations difficult. In resource-restricted rural/semi-rural environments, identification of feasible
screening tools is a priority. The objective of this study was to evaluate gestational anthropometry in relation to
birth and infant growth in a rural/semi-rural Tanzanian prospective cohort of mothers and their infants.
Methods: Mothers (n = 114: 44 HIV-positive) attending antenatal clinic visits were recruited in their second or third
trimester between March and November, 2012, and followed with their infants through 6-months post-partum.
Demographic, clinical, and infant feeding data were obtained using questionnaires administered by a Swahili-
speaking research nurse on demographic, socioeconomic, clinical, and infant feeding practices. Second or third
trimester anthropometry (mid-upper arm circumference [MUAC], triceps skinfold thickness, weight, height),
pregnancy outcomes, birth (weight, length, head circumference) and infant anthropometry (weight-for-age z-score
[WAZ], length-for-age z-score [LAZ]) were obtained. Linear regression and mixed effect modeling were used to
evaluate gestational factors in relation to pregnancy and infant outcomes.
Results and discussion: Gestational MUAC and maternal HIV status (HIV-positive mothers = 39 %) were associated
with infant WAZ and LAZ from birth to 6-months in multivariate models, even after adjustment for infant
feeding practices. The lowest gestational MUAC tertile was associated with lower WAZ throughout early
infancy, as well as lower LAZ at 3 and 6-months. In linear mixed effects models through 6-months, each 1 cm
increase in gestational MUAC was associated with a 0.11 increase in both WAZ (P < 0.001) and LAZ (P = 0.001). Infant
HIV-exposure was negatively associated with WAZ (β = -0.65, P < 0.001) and LAZ (β = -0.49, P < 0.012) from birth to
6-months.
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Conclusions: Lower gestational MUAC, evaluated using only a tape measure and minimal training that is feasible in
non-urban clinic and community settings, was associated with lower infant anthropometric measurements. In this rural
and semi-rural setting, HIV-exposure was associated with poorer anthropometry through 6-months despite maternal
antiretroviral access. Routine assessment of MUAC has the potential to identify at-risk women in need of additional
health interventions designed to optimize pregnancy outcomes and infant growth. Further research is needed to
establish gestational MUAC reference ranges and to define interventions that successfully improve MUAC during
pregnancy.
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Background
Maternal malnutrition is an important risk factor for
adverse infant outcomes, including low birth weight
(LBW) [1]. Birth weight represents a key barometer
of fetal health, and LBW infants are at increased risk
of morbidity and mortality [2]. While maternal nutri-
tional status is a useful predictor of pregnancy and
birth outcomes [3], evaluating maternal nutritional
status in resource-restricted regions remains challenging.
Maternal height and weight are frequently unavailable,
and if recorded, often inaccurate since adult weigh scales
are costly to obtain and maintain calibrated. Clinical
observation may be unreliable as maternal malnutrition
can be masked by pregnancy-associated weight gain and
fluid shifts.
Tanzania promotes the World Health Organization
(WHO) antenatal care recommendations that include
measuring weight gain, fundal height, hemoglobin, urinary
albumin and glucose at antenatal visits, and measuring
height plus screening for HIV and syphilis at least once
[4]. While these indicators can identify severe maternal
malnutrition and clinical complications, pregnant women
with mild or moderate malnutrition may remain un-
identified. Failure to recognize these women essen-
tially eliminates any opportunity for them to receive
additional monitoring and/or interventions that may
prevent negative fetal and/or infant consequences.
The workload burden of healthcare workers in this
setting is considerable [5], and the identification of
at-risk pregnancies represents the crucial first step to-
wards achieving better maternal, fetal and infant care
calls for quick, inexpensive, and feasible assessment –
in essence, a point-of-care test (POCT).
Maternal MUAC measured during gestation has been
shown to be associated with LBW in a number of African
and Asian studies [6], although no reference ranges have
been established. Despite widespread usage of MUAC to
identify malnutrition in pediatric populations [7, 8], and to
a lesser extent in pregnant and lactating women [9], gesta-
tional MUAC as a predictor of poor fetal or early infancy
growth has not yet been recommended by WHO or
any other public health agency. A non-governmental
organization operating in humanitarian crisis settings,
Médecins Sans Frontières, has recommended the use of
maternal MUAC <23 cm to identify women at risk of
delivering LBW infants based on the strength of the
association between maternal MUAC and LBW and
the simplicity of obtaining gestational MUAC measure-
ments, without requiring knowledge of gestational age
[10]. These same features suggest that maternal MUAC
may be useful in non-urban health care and community
settings in developing countries, and thus, the objective of
this study was to investigate current Tanzanian standard
antenatal (height, weight) and non-standard [MUAC,
triceps skinfold thickness (TSF)] gestational anthropo-
metric measurements in HIV-positive and HIV-negative
women in association with birth and early infant growth
in a prospective rural and semi-rural Tanzanian cohort.
Methods
Study setting and population
A prospective cohort of 44 HIV-positive and 70 HIV-
negative pregnant women living in Magu District,
Tanzania, was established between March to November
2012, with cohort observation continuing through July
2013. Participants were recruited from women seeking
antenatal services at rurally-located dispensaries, repre-
senting the first level of public health care in Tanzania,
and from women attending antenatal visits at Kisesa
Health Centre, a publically accessible government-
administrated healthcare facility located in the semi-
rural region around Kisesa Village. Kisesa Health Centre
offers basic antenatal and obstetrical services, outpatient
child and adult healthcare, and provides HIV counsel-
ling, testing, and treatment. The clinic serves a large
catchment area in the vicinity of Kisesa Village, located
approximately 20 kilometers from the city of Mwanza.
Participants in this observational study that were identi-
fied as malnourished or requiring additional clinical
follow-up for any condition were referred via the study
physician liaison to the main clinical services of Kisesa
Health Centre. Mothers provided written informed con-
sent for themselves and on behalf of their infants. Ethical
approval for this study was granted by the Tanzanian
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National Health Research Ethics Review Committee and
the Cornell University Institutional Review Board.
Study eligibility included stated intention to live within
the antenatal clinic catchment area until 6-months post-
partum, confirmed maternal HIV serostatus [screening by
Determine™ HIV-1/2 (Inverness Medical), confirmation by
Uni-Gold™ HIV-1/2 (Trinity Biotech)] at enrollment, and
singleton pregnancy (any eligible pregnant woman was en-
rolled, but they were subsequently withdrawn if a multiple
delivery was confirmed). All HIV-positive women who
met the eligibility criteria were invited to participate and
HIV-negative women were invited to participate in the
study at approximately double the rate as HIV-negative
women joined, although there was no specific matching
strategy employed. The required sample sizes for statis-
tical analyses assuming α = 0.05 (two-sided), power = 80 %
and when applicable, unequal group size in the ratio = 2:1,
varied according to the statistical procedure (e.g. Student’s
t-test, Chi-squared test, adjusted and unadjusted linear re-
gression) and cohort participants included (e.g. maternal
analyses only, infant only, both). The sample size recruited
exceeded that required to detect mean differences in birth
weight (mean/standard deviation = 300/425 g), birth
length (1.25/2.00 cm), head circumference (1.0 /1.5 cm),
birth MUAC (0.75/2.00 cm), gestational age at birth
(1.5/2.5 weeks). Detectable linear regression effect sizes
were targeted between small to medium effects for un-
adjusted (by convention small to medium effect size set at
0.02 < f < 0.15) to medium to large (by convention
medium to large effect size set at 0.15 < f < 0.35) for ad-
justed (one predictor, six covariates) regression models.
Women were enrolled in the cohort after completing
their first trimester. A follow-up visit was scheduled during
pregnancy if the original enrollment date preceded the an-
ticipated delivery date by ≥3 weeks. All women were
followed-up at delivery if they delivered at Kisesa Health
Centre or within 72 h if they delivered elsewhere. There-
after, women were followed with their infants at 1, 2, 3, and
6-months postpartum. Mother-infant follow-up visits cor-
responded to Tanzanian infant vaccination visits, with the
exception of a study-specific visit at 6-months. If a mother-
infant pair failed to return for a follow-up visit, a field
worker traveled to their last known address to invite them
to return to the clinic for a rescheduled appointment. Re-
cruitment and retention strategies included compensating
participants for transportation expenses as region-specific
surveys indicated transportation expenses were a significant
barrier to accessing clinic-based services in this region [11].
Maternal HIV testing is offered as part of routine
antenatal care in Tanzania and many women are first
diagnosed with HIV infection during pregnancy. At
the time of this study, Tanzania followed Option A of
the WHO 2010 prevention of mother-to-child transmission
(PMTCT) guidelines [12]. Women with absolute CD4 cell
counts ≤350 cells/μL or WHO clinical stage 3 or 4 irre-
spective of CD4 cell count were eligible for a first-line com-
bination antiretroviral regimen, consisting of zidovudine
(AZT) + lamivudine (3TC) + efavirenz (EFV). All other
HIV-positive women received AZT for PMTCT starting as
early as 14 weeks gestation. HIV-exposed infants were pre-
scribed daily nevirapine for six weeks, followed by HIV test-
ing at 3-months of age using dried blood spot HIV DNA-
PCR that was analyzed at Bugando Medical Centre in
Mwanza City, the closest regional hospital laboratory. Out
of the 38 HIV-exposed infants enrolled in the cohort at de-
livery, 32 (84 %) tested negative for HIV at 3-months and 6
(16 %) exited the study prior to HIV testing (Fig. 1).
Data collection
Demographic, medical history, and infant feeding data
were obtained through questionnaires administered by a
Swahili-speaking research nurse. In the absence of ultra-
sound technology, participants were counseled to estimate
their last menstrual period from which gestational age was
approximated, or for the 6 % (n = 7/114) of women unable
to estimate their last menstrual period, gestational age was
estimated from the first available fundal height according
to standard clinic procedures. All maternal and infant an-
thropometric measurements were collected by trained re-
search nurses. Gestational anthropometric measurements
were collected upon enrollment that corresponded to the
second or third trimester of pregnancy, and included
weight, height, MUAC, and TSF. Maternal weight and
height were measured using a standard balance beam
scale with a height rod (Health O Meter, Inc., Bridgeview,
IL) to the precision of 0.2 kg and 0.1 cm, respectively.
MUAC was measured by tape measure to the nearest
0.1 cm and TSF was measured by Lange Skin Calipers
(Cambridge Scientific Industries, Cambridge, MD) to the
nearest 0.1 mm. Maternal blood was drawn for
hemoglobin quantification and anemia was defined as
hemoglobin (Hb) concentration <11 g/dL and severe
anemia as Hb <8.5 g/dL according to reference values
used for clinical referral in Tanzania [13]. All women iden-
tified as anemic were referred for clinical follow-up at
Kisesa Health Centre. Infant birth anthropometric mea-
surements (weight, height, head circumference, MUAC)
were included in the birth anthropometry analyses if col-
lected within 72 h of delivery (Fig. 1). Infant anthropom-
etry was measured at 1, 2, 3 and 6-months. Infant weight
and length were measured using a digital infant scale
(Seca 334 Digital Baby Scale) to the nearest 0.01 kg and
0.1 cm, respectively, and infant tape measures were used
to measure both infant head circumference and MUAC to
the nearest 0.1 cm.
Exclusive breastfeeding was defined according to the
WHO definition, which allows for the infant to receive
only breast milk and medications, oral rehydration
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solutions, vitamins and minerals [14]. Exclusive breast-
feeding duration was defined as the period between birth
and the age at which the infant first received food or
non-breast milk liquids, other than medications. A
study-specific breastfeeding score was evaluated at each
visit, and the individual visit scores were summed to
provide an overall breastfeeding score. Infant feeding
practices were scored as: 0 = no breastfeeding; 1 = partial
breastfeeding (defined as breast milk plus other foods
and/or liquids); 2 = predominant breastfeeding (defined
as breast milk plus locally-prepared non-prescription
anti-colic/anti-gripe water); 3 = exclusive breastfeeding.
The overall breastfeeding score summarized infant feed-
ing practices over the one to 6-month period, with
scores ranging from 0 to 12. An example score for an in-
fant exclusively breastfed for 6-months would include a
visit-specific breastfeeding score of 3 at each of 4 follow-
up visits = 12. An example score for an infant who was
exclusively breastfeeding at month-1, transitioned to
predominant breastfeeding at month-2, transitioned to
partial breastfeeding at month-3 and stopped all breast-
feeding by the month-6 visit would be 3 + 2 + 1 + 0 = 6. If
a mother missed a follow-up visit, information regarding
infant feeding practices for the relevant month was
ascertained at the subsequent study visit.
Statistical analysis
Data were analyzed in STATA12 (STATA Corporation,
Texas, USA). Means of normally-distributed continuous var-
iables were compared using Student’s t-test and one-way
analysis of variance (ANOVA) was used for comparisons of
means across categorical variables. Proportions of categorical
variables were compared using Pearson chi-square tests. Re-
lationships between infant anthropometrics at birth and ges-
tational clinical characteristics were analyzed using both
unadjusted linear regression models, and linear regression
models adjusted for covariates chosen a priori (maternal
HIV status, age, parity, education, gestational age at the time
of anthropometric measurement, and infant sex). Gestational
MUAC was examined as both a continuous and categorical
variable classified according to study-specific data-derived
tertiles because there are no established gestational MUAC
reference values. Infant weight-for-age (WAZ) and length-
for-age (LAZ) z-scores were calculated using the WHO
Child Growth Standards with the igrowup macro package
(freely available at: www.who.int/childgrowth/software/en).
Fig. 1 Maternal and infant cohort follow-up
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Underweight and stunting were defined as having a z-
score < -2 standard deviations below the WHO reference
standards for WAZ and LAZ, respectively. Mixed effect
models were used to compare infant growth trajectories
between groups (HIV-exposed vs. HIV-unexposed and low
vs. high gestational MUAC). For these analyses, MUAC
was dichotomized into “low” and “high”, with low MUAC
defined as MUAC is the lowest tertile of the cohort distri-
bution and high MUAC defined as MUAC in the middle
and highest tertiles combined. Posthoc pairwise compari-
sons were made at each age corresponding to study visit
(birth, 1, 2, 3, and 6-months) and were based on estimated
margins means. To account for multiple comparisons, the
Bonferroni correction procedure was used in these ana-
lyses. Mixed effect models were also used to examine the
relationships between infant anthropometry and covariates
of interest (HIV and gestational MUAC), with adjustment
for potential confounding variables.
Results
Maternal characteristics
Characteristics of the 44 HIV-positive and 70 HIV-
negative women enrolled in the study and their infants
are summarized in Table 1. Mean BMI did not differ
Table 1 Characteristics of pregnant women and their newborn infants in a prospective cohort, Tanzania, 2012-2013a
Maternal HIV status Gestational MUAC at enrollment (cm)
Characteristics Overall Positive Negative P ≤25.5 25.6-27.9 ≥28.0 P
(n = 114) (n = 44) (n = 70) (n = 42) (n = 35) (n = 37)
Maternal characteristics at enrollment
Gestational age at enrollment, weeks 26.9 ± 6.9 23.7 ± 7.1 28.9 ± 6.0 <0.001b 28.5 ± 5.8 25.4 ± 7.2 26.4 ± 7.4 0.135c
Age, y 28.0 ± 6.0 28.9 ± 6.0 27.4 ± 6.0 0.192b 27.4 ± 5.8 27.2 ± 5.6 29.4 ± 6.5 0.202c
Married, % 86.8 72.7 95.7 <0.001d 85.7 91.4 83.8 0.608d
Primiparous, % 14.0 15.9 12.9 0.648d 16.7 14.3 10.8 0.755d
Mid-upper arm circumference, cm 26.9 ± 2.7 27.3 ± 2.9 26.6 ± 2.5 0.192b 24.2 ± 1.2a 26.9 ± 0.6b 29.9 ± 1.6c <0.001c
Triceps skinfold thickness, mm 14.1 ± 5.4 14.6 ± 5.1 13.9 ± 5.5 0.499b 10.2 ± 2.6a 13.6 ± 3.8b 19.1 ± 5.1c <0.001c
Weight, kg 60.0 ± 7.8 60.3 ± 8.2 60.0 ± 7.6 0.859b 54.4 ± 5.2a 59.0 ± 5.1b 67.2 ± 6.8c <0.001c
Height, cm 160.0 ± 5.5 160.1 ± 5.3 159.8 ± 5.7 0.788b 159.3 ± 5.3 160.3 ± 5.9 160.4 ± 5.6 0.611c
Body mass index, kg/mb 23.4 ± 2.6 23.4 ± 2.9 23.4 ± 2.5 0.928b 21.4 ± 1.4a 23.0 ± 1.8b 26.1 ± 2.0c <0.001c
HIV-positive, % 38.6 100.0 – – 33.3 34.3 48.7 0.310d
CD4 cell count, cells/μL (n = 43)5 – 560 ± 290 – – 568 ± 272 535 ± 274 572 ± 326 0.939c
<200 cells/μL (n = 4),% – 9.3 – – 7.7 16.7 5.6 0.194d
200 to 349 (n = 7), % – 16.3 – – 7.7 0.0 33.3 –
350 to 499 (n = 12), % – 27.9 – – 30.8 41.7 16.7 –
≥500 (n = 20), % – 46.5 – – 53.9 41.7 44.4 –
(n = 100) (n = 38) (n = 62) (n = 39) (n = 29) (n = 32)
Infant characteristics at birthf
Gestational age at birth, weeks (n = 100) 38.2 ± 3.4 37.7 ± 3.0 38.4 ± 3.6 0.274b 37.6 ± 3.8 37.9 ± 3.3 39.0 ± 2.9 0.198c
Preterm birth (<37 weeks), % 30.0 34.2 27.4 – 30.8 31.0 28.1 –
Birth weight, g (n = 88) 3183 ± 448 3039 ± 493 3274 ± 396 0.016b 3064 ± 440 3209 ± 456 3290 ± 434 0.124c
Low birth weight (<2500 g), % 4.6 5.9 3.7 – 6.1 8.3 0.0 –
Birth length, cm (n = 76) 46.7 ± 2.0 46.0 ± 2.4 47.1 ± 1.6 0.026b 46.1 ± 1.9a 46.4 ± 2.2a,b 47.4 ± 1.8b 0.036c
Birth mid-upper arm circumference, cm (n = 76) 10.7 ± 1.1 10.6 ± 1.1 10.8 ± 1.0 0.397b 10.2 ± 2.2 9.6 ± 3.3 10.3 ± 2.9 0.694c
Birth head circumference, cm (n = 76) 34.6 ± 1.6 34.2 ± 1.4 34.7 ± 1.7 0.183b 34.0 ± 1.4 35.1 ± 1.7 34.7 ± 1.7 0.056c
Abbreviations: HIV human immunodeficiency virus, MUAC mid-upper arm circumference. The “–” symbol indicates data that are not applicable
aValues are means ± standard deviation or frequencies
bStudent’s t-test for comparisons of means between groups based on maternal HIV status as HIV-positive vs HIV-negative mothers
cOne-way ANOVA test for comparisons of means between groups based on gestational MUAC values of MUAC = ≤25.5 vs 25.6 to 27.9 vs ≥28.0 cm; for significant
results, post hoc comparisons were made. Different superscript letters denote significant differences (P < 0.05) between the groups
dPearson chi-square test for comparison of proportions
eCD4 cell count available from HIV-positive women only; CD4 was missing from one HIV-positive participant
fAll birth anthropometric measurements were obtained within 72 h of birth. Birth data were available from 100/114 of the original cohort participants as 5/114 of
pregnancies ended in miscarriage or stillbirth and 9/114 women exited the study prior to giving birth
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significantly by maternal HIV status. Gestational MUAC
(tertile) was positively associated with gestational TSF,
weight, and BMI (for all, ANOVA P < 0.001). The
average gestational age was 27 weeks at study enroll-
ment (range: 13-39 weeks), with HIV-positive women
enrolling significantly earlier in pregnancy. Most
women were married (87 %) and multiparous (86 %),
and while the majority (89 %) of women reported be-
ing formally educated, only 11 % advanced beyond
the primary school level. Few households had electri-
city (10 %), and many women worked to generate
household income (78 %).
Overall, hemoglobin concentration was low (mean ±
standard deviation: 10.1 ± 1.8 g/dL), and anemia com-
mon (55 %, Hb <11.0 g/dL), with 11 % severely anemic
(Hb <8.5 g/dL). Neither anemia nor severe anemia
frequencies differed according to maternal HIV status
(P = 0.494; P = 0.980, respectively), and HIV-positive
women were not statistically different from HIV-negative
women in their mean anthropometric indicators. Among
HIV-positive women, advanced immunosuppression was
rare as 3/4 had CD4 ≥ 350 cells/μL and almost half
(46.5 %) had normal absolute CD4 cell counts (≥500 cells/
μL). At enrollment, ART regimens included: 1) no ART
(n = 5; 11 %); 2) triple therapy (AZT + 3TC + EFV; n = 15;
34 %) or 3) AZT monotherapy (n = 24; 55 %). Of the five
women who were not receiving ART at enrollment, three
initiated AZT before their next antenatal visit, one with-
drew from the study, and one miscarried. All women who
were taking triple therapy reported initiating this regimen
for their own HIV care prior to becoming pregnant.
Among those women who were prescribed AZT for
PMTCT during pregnancy, 11 % initiated AZT during
their first trimester, 79 % in their second and 11 % during
their third trimester. By delivery, all HIV-positive women
were receiving either triple therapy for their own HIV
management, or AZT for PMTCT.
Pregnancy outcomes and birth anthropometrics
In this rural and semi-rural cohort, 5 % of pregnancies
ended in stillbirth or miscarriage, almost 1/3 delivered
preterm, and 5 % of infants were born LBW (Table 1).
HIV-positive mothers experienced a greater proportion
of adverse outcomes (combined fetal death, preterm de-
livery, LBW: 41 vs 31 %, P = 0.29), and delivered babies
with lower average birth weight and length. Infant birth
weight was available from 89 % (34/38) of HIV-positive
mothers and 87 % (54/62) of HIV-negative mothers who
remained in the cohort through delivery (P = 0.72 for
comparison) and complete infant birth anthropometric
data were available from 76 % (29/38) of HIV-positive
mothers and 76 % (47/62) of HIV-negative mothers (P =
0.95). Decreasing gestational MUAC tertiles were associ-
ated with decreasing birth length (ANOVA P = 0.036;
Table 2). In adjusted regression models (Table 3), maternal
HIV-seropositivity was associated with lower mean
birth weight (-280 g; P = 0.013) and length (-1.03 cm;
P = 0.052).
Gestational MUAC, TSF, and BMI at enrollment were
each associated with greater infant birth length, and ma-
ternal weight during pregnancy was positively associated
with birth weight and length. Gestational MUAC (tertile)
remained significantly associated with birth length in ad-
justed analyses (Table 3). In the adjusted analyses of
birth outcomes, interactions between gestational MUAC
and HIV were examined, but were not statistically
significant (interaction p-values: gestational age at de-
livery, P = 0.231; birth weight P = 0.446; birth length,
P = 0.474; birth MUAC, P = 0.602; birth head circum-
ference, P = 0.075).
Infant growth
Unadjusted infant anthropometry data is summarized in
Table 4. In this rural and semi-rural cohort, the number of
infants classified as stunted increased throughout early in-
fancy with the majority being stunted by 6-months (57 %,
n = 51). HIV-exposed infants were disproportionally
affected by underweight and stunting throughout the first
6-months. In growth models adjusted for gestational age at
enrollment, HIV-exposed infants had significantly lower
WAZ at 2, 3 and 6-months and lower LAZ at 2-months
(Fig. 2a-b). Infant growth differences based on HIV-
exposure persisted, despite HIV-positive women reporting
a longer mean duration of exclusive breastfeeding (HIV-
positive: 6.6 ± 1.4 weeks vs. HIV-negative: 3.4 ± 0.7 weeks;
P = 0.03) and a significantly higher breastfeeding score
(HIV-positive: 7.5 ± 0.4 vs. HIV-negative: 6.1 ± 0.3; P =
0.004). Infant growth outcomes also differed according to
gestational MUAC. “Low” gestational MUAC (correspond-
ing to the lowest tertile of the cohort distribution and a
MUAC of ≤25.5 cm) was associated with significantly lower
WAZ throughout infancy and lower LAZ at 3 and 6-
months compared to high gestational MUAC (correspond-
ing to the middle and highest tertiles combined, and a
MUAC >25.5 cm) (Fig. 2c-d). Infant feeding practices did
not differ according to gestational MUAC (low vs. high
MUAC comparisons; exclusive breastfeeding duration, P =
0.539; breastfeeding score, P = 0.377). Among the infants in
this cohort, those with dual adverse maternal exposures
(HIV-positive mothers with gestational MUAC in the low-
est terile) had the poorest growth from birth through 6-
months based on both WAZ and LAZ (Fig. 3). Mixed
effect models of infant growth adjusted for potential con-
founding factors confirm the significant association be-
tween maternal HIV and maternal nutritional status
according to gestational MUAC with early infant growth
outcomes (Table 5). MUAC, modeled as a continuous vari-
able, was also significantly associated with infant WAZ and
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LAZ, with each 1 cm increase in maternal MUAC associ-
ated with a +0.11 (P < 0.001) increase in infant WAZ, as
well as a +0.11 (P = 0.001) increase in infant LAZ. Infant
HIV-exposure had statistically significant, negative associa-
tions with WAZ (β = -0.65, P < 0.001) and LAZ (β = -0.49,
P < 0.012) from birth to 6-months in mixed effect models.
Again, interactions were examined between maternal HIV
and gestational MUAC in these growth models, but they
were not statistically significant (interaction p-values:
WAZ P = 0.138; LAZ P = 0.525).
Table 2 Unadjusted linear regression of infant birth outcomes with maternal HIV status and nutritional status at enrollment
Main predictor Gestational age at birth,
wk (n = 100)
Birth weight, g
(n = 88)
Birth length, cm
(n = 76)
Birth MUAC, cm
(n= 76)
Birth head circumference,
cm (n= 76)
β P 95 % CI β P 95 % CI β P 95 % CI β P 95 % CI β P 95 % CI
MUAC, cm 0.21 0.09 -0.04, 0.46 26.11 0.13 -8.10, 60.32 0.18 0.03 0.02, 0.35 0.06 0.16 -0.02, 0.15 0.05 0.45 -0.09, 0.19
TSF, mm 0.08 0.23 -0.05, 0.20 9.30 8.56 -7.71, 26.32 0.09 0.04 0.01, 0.17 0.03 0.13 -0.01, 0.08 0.04 0.25 -0.03, 0.11
Weight, kg 0.02 0.70 -0.07, 0.10 11.69 0.04 0.33, 23.05 0.06 0.03 0.00, 0.11 0.03 0.05 0.00, 0.06 0.01 0.59 -0.03, 0.06
Height, cm -0.03 0.61 -0.15, 0.09 8.80 0.31 -8.26, 25.85 0.03 0.46 -0.05, 0.11 0.01 0.50 -0.03, 0.06 -0.01 0.79 -0.08, 0.06
BMI, kg/m2 0.10 0.13 -0.15, 0.35 29.07 0.10 -5.60, 63.73 0.18 0.03 0.01, 0.35 0.09 0.05 -0.00, 0.18 0.05 0.46 -0.09, 0.19
HIV-seropositivity -0.77 0.27 -2.16, 0.62 -234.53 0.02 -424.07, -44.99 -1.04 0.03 -1.95, -0.13 -0.25 0.70 -1.52, 1.03 -0.51 0.18 -1.28, 0.25
Mean ± SD P Mean ± SD P Mean ± SD P Mean ± SD P Mean ± SD P
MUAC tertilea
(MUAC range)
Tertile 1
(20.7-25.5 cm)
37.6 ± 0.5 0.198 3064 ± 77 0.124 46.1 ± 0.4a 0.036 10.5 ± 0.2 0.208 34.0 ± 0.3 0.056
Tertile 2
(25.7-27.8 cm)
37.9 ± 0.6 3209 ± 90 46.4 ± 0.4a,b 10.6 ± 0.2 35.1 ± 0.4
Tertile 3
(28.0-33.5 cm)
39.0 ± 0.6 3290 ± 79 47.4 ± 0.4b 11.0 ± 0.2 34.7 ± 0.3
Abbreviations: HIV human immunodeficiency virus, MUAC mid-upper arm circumference, HC head circumference, BMI body mass index, TSF triceps
skinfold thickness
aData are predicted means and standard deviations: for significant results, post hoc comparisons were made. Groups with different subscript letters are
significantly different (P < 0.05)
Table 3 Adjusted linear regression of infant birth outcomes with maternal HIV status and nutrition at enrollment
Main predictor Gestational age at birth,
wk (n = 100)
Birth weight, g
(n = 88)
Birth length, cm
(n = 76)
Birth MUAC, cm
(n = 76)
Birth head circumference,
cm (n = 76)
β P 95 % CI β P 95 % CI β P 95 % CI β P 95 % CI Β P 95 % CI
MUAC, cm 0.24 0.06 -0.01, 0.50 27.44 0.12 -7.26, 62.15 0.21 0.01 0.04, 0.38 0.06 0.23 -0.04, 0.15 0.08 0.31 -0.07, 0.22
TSF, mm 0.08 0.24 -0.05, 0.21 10.56 0.24 -7.11, 28.23 0.09 0.04 0.01, 0.17 0.03 0.19 -0.02, 0.08 0.05 0.14 -0.02, 0.13
Weight, kg 0.01 0.89 -0.08, 0.09 13.89 0.02 2.50, 25.28 0.06 0.04 0.00, 0.11 0.03 0.04 0.00, 0.06 0.01 0.53 -0.03, 0.06
Height, cm -0.03 0.62 -0.16, 0.09 12.71 0.14 -4.37, 29.78 0.04 0.30 -0.04, 0.13 0.02 0.35 -0.02, 0.07 -0.00 0.98 -0.07, 0.07
BMI, kg/mb 0.06 0.66 -0.20, 0.31 31.41 0.08 -3.32, 66.14 0.16 0.06 -0.01, 0.33 0.09 0.06 -0.00, 0.18 0.05 0.48 -0.09, 0.20
HIV-seropositivity -0.18 0.82 -1.74, 1.38 -280.38 0.01 -500.80, -59.96 -1.03 0.05 -2.08, 0.01 -0.21 0.78 -1.66, 1.25 -0.41 0.36 -1.29, 0.48
Mean ± SD P Mean ± SD P Mean ± SD P Mean ± SD P Mean ± SD P
MUAC tertileb
(MUAC range)
Tertile 1
(20.7-25.5 cm)
37.5 ± 0.5 0.159 3062 ± 78 0.119 46.0 ± 0.4a 0.016 10.7 ± 0.9 0.252 33.9 ± 0.3a 0.025
Tertile 2
(25.7-27.8 cm)
38.0 ± 0.6 3185 ± 91 46.4 ± 0.4a,b 10.6 ± 0.9 35.2 ± 0.4b
Tertile 3
(28.0-33.5 cm)
39.1 ± 0.6 3311 ± 81 47.5 ± 0.4b 11.1 ± 0.9 34.8 ± 0.3a,b
aAll models have been adjusted for maternal age, parity, education, gestational age at the time of gestational anthropometric measurement, and infant gender.
Models with gestational nutritional indicators as the main predictor have also been adjusted for maternal HIV status. Abbreviations: HIV human immunodeficiency
virus, MUAC mid-upper arm circumference, HC head circumference, BMI body mass index, TSF triceps skinfold thickness
bData are predicted means and standard deviations, adjusted for the covariates listed in footnote 1; for significant results, post hoc comparisons were made.
Groups with different subscript letters are significantly different (P < 0.05)
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Discussion
Many studies have demonstrated an association between
maternal nutritional status and birth outcomes [15, 16],
however there is limited data extending this link to in-
fant growth outcomes. In this prospective cohort of
mothers and infants living in northwestern Tanzania,
maternal nutritional status defined by gestational MUAC
was not only associated with poorer birth anthropomet-
rics, but also ongoing suboptimal infant growth up to
6-months of age. HIV-exposed infants were at greater
risk of poorer growth outcomes in this study, despite
earlier antenatal care and comparatively better infant
feeding practices (although exclusive breastfeeding
duration in both groups fell short of WHO recom-
mendations). This provides evidence that HIV-
exposed, uninfected infants have poorer birth and
growth outcomes in this rural and semi-rural setting.
Poorer growth patterns among HIV-infected children
are well-documented and several studies have ob-
served differences in growth outcomes between HIV-
exposed, uninfected and HIV-unexposed infants in
sub-Saharan Africa [17, 18]; however, there is also
evidence suggesting that postnatal growth is similar
between HIV-exposed, uninfected and HIV-uninfected
children, or that differences between groups are small
and transient [19, 20].
Among 1005 HIV-positive Malawian women living in
an urban setting, MUAC measured at the study enroll-
ment in pregnancy was positively associated with birth
weight, and the risk of experiencing a LBW delivery de-
creased significantly with increasing maternal gestational
MUAC [21]. In 1002 HIV-positive pregnant Tanzanian
women residing in the capital city of Dar es Salaam,
women with MUAC values in the highest quartile gave
Table 4 Early infancy anthropometry, stratified by HIV exposure and gestational mid-upper arm circumference at enrollmenta
Age 0 (birth) 1-month 2-months 3-months 6-months
Overall N 88 88 87 91 89
Weight-for-age z-score -0.27 (-0.48, -0.52) -0.23 (-0.47, -0.00) -0.15 (-0.42, 0.12) -0.28 (-0.55, 0.01) -0.41 (-0.68, -0.13)
Length-for-age z-score -1.52 (-1.76, -1.28)b -1.70 (-2.01, -1.38) -1.77 (-2.09, -1.44) -1.75 (-2.05, -1.45) -2.35 (-2.70, -1.99)
Underweight, % 3.4 4.6 8.1 8.8 6.7
Stunting, % 25.0 44.3 48.3 41.1 57.3
HIV-exposed N 34 36 33 34 33
Weight-for-age z-score -0.61 (-1.00, -0.22)* -0.63 (-1.06, -0.20)** -0.67 (-1.16, -0.18)** -0.86 (-1.34, -0.38)*** -0.88 (-1.40, -0.36)**
Length-for-age z-score -1.89 (-2.39, -1.40)*b -1.99 (-2.53, -1.44) -2.27 (-2.85, -1.70)* -2.10 (-2.63, -1.56) -2.71 (-3.27, -2.15)
Underweight,% 5.9 11.1* 18.2** 17.7* 15.2*
Stunting, % 37.9* 55.6 63.6* 48.9 66.7
HIV-unexposed N 54 52 54 57 56
Weight-for-age z-score -0.05 (-0.29, 0.19) 0.04 (-0.20, 0.28) 0.17 (-0.13, 0.46) 0.06 (-0.24, 0.36) -0.13 (-0.42, 0.17)
Length-for-age z-score -1.29 (-1.53, -1.05)b -1.49 (-1.87, -1.11) -1.46 (-1.84, -1.07) -1.55 (-1.91, -1.19) -2.13 (-2.60, -1.67)
Underweight, % 1.9 0.0 1.9 3.5 1.8
Stunting, % 17.0 36.5 38.9 36.8 51.8
Low gestational
mid-upper arm
circumference
N 33 32 33 36 35
Weight-for-age z-score -0.53 (-0.90, -0.15) -0.65 (-1.04, -0.27)** -0.53 (-0.96, -0.11)* -0.75 (-1.14, -0.36)** -0.86 (-1.23, -0.49)**
Length-for-age z-score -1.81 (-2.20, -1.43)b -1.83 (-2.34, -1.32) -1.82 (-2.36, -1.28) -2.21 (-2.64, -1.77) -2.93 (-3.60, -2.26)**
Underweight, % 6.1 6.3 9.1 11.1 8.6
Stunting, % 32.1 43.8 48.5 52.8 71.4*
High gestational
mid-upper arm
circumference
N 55 56 54 55 54
Weight-for-age z-score -0.11 (-0.37, 0.15) 0.01 (-0.27, 0.28) 0.09 (-0.26, 0.43) 0.02 (-0.33, 0.38) -0.11 (-0.48, 0.26)
Length-for-age z-score -1.35 (-1.66, -1.04)b -1.62 (-2.03, -1.21) -1.73 (-2.16, -1.31) -1.45 (-1.84, -1.06) -1.97 (-2.35, -1.58)
Underweight, % 1.8 3.6 7.4 7.3 5.6
Stunting, % 20.8 44.6 48.2 33.3 48.2
aData are unadjusted means and 95 % confidence intervals. “Low” gestational mid-upper arm circumference was classified as the lowest tertile of the cohort
distribution (range: 20.7-25.5 cm) and high as the middle and highest tertiles combined (range: 25.7-33.5 cm). Significant differences between groups (HIV-exposed
vs. HIV-unexposed; low vs. high gestational mid-upper arm circumference at enrollment) were tested using Student’s t-test for continuous variable and Pearson
chi-square test for categorical outcomes (underweight and stunting); *P < 0.05, **P < 0.01, ***P < 0.001
bLength measurements at birth were available from n = 76 participants (HIV-exposed: n = 29; HIV-unexposed: n = 47; Low gestational mid-upper arm circumference:
n = 28; High gestational mid-upper arm circumference: n = 48)
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birth to infants with higher mean birth weights compared
to women with MUAC in the lowest quartile, but no asso-
ciation with LBW was observed [22]. The current study is
consistent with these observations, and extends these
findings by demonstrating this association in a non-urban
setting, and uniquely, that gestational MUAC is associated
with early infancy anthropometrics and growth up to 6-
months of age. While many factors occurring after birth
can positively or negatively alter growth trajectories, un-
derstanding gestational influences indicates appropriate
targets (e.g. women) and timing (e.g. during pregnancy) to
prevent negative infant growth outcomes.
Fig. 2 Mean weight-for-age and length-for-age z-scores, stratified on infant HIV-exposure or gestational mid-upper arm circumference. Models
stratified on infant HIV-exposure (a and b, where “HIV-U” = infant HIV-unexposed, “HIV-E” = infant HIV-exposed) or gestational mid-upper arm
circumference (c and d, where “Low MUAC” = lowest gestational mid-upper arm circumference tertile, “High MUAC” =middle and highest tertiles
combined). Dotted lines depict z-scores of zero. All models adjusted for gestational age; post hoc pairwise comparisons used to generate
predicted marginal means and 95 % CI at each time point. *P < 0.01, **P < 0.001
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A strong and urgent call for POCT to improve health
has been made from resource-restricted regions [23].
The ideal POCT has been described according to the
ASSURED criteria (developed at the 2003 WHO Special
Programme for Research and Training in Tropical
Diseases) as being affordable, sensitive, specific, user-
friendly, robust and rapid, equipment-free (or requiring
minimal equipment), and deliverable [24, 25]. Gestational
MUAC appears to be an ideal POCT candidate, requiring
a simple tape measure and minimal assessor training.
In the current study, a gestational MUAC of ≤25.5 cm
(corresponding to the lowest MUAC tertile) was associated
Fig. 3 Mean weight-for-age and length-for-age z-scores, stratified on infant HIV-exposure plus gestational mid-upper arm circumference. Models stratified
on infant HIV-exposure (Fig. 2a and b, where “HIV-U” = infant HIV-unexposed, “HIV-E”= infant HIV-exposed) or gestational mid-upper arm circumference
(Fig. 2c and d, where “Low MUAC”= lowest gestational mid-upper arm circumference tertile, “High MUAC”=middle and highest tertiles combined).
Dotted lines depict z-scores of zero. All models adjusted for gestational age; post hoc pairwise comparisons were used to generate predicted marginal
means and 95 % CI at each time point and the significance threshold after Bonferroni correction; significance was P< 0.01. Significant differences were
observed for the following weight-for-age z-scores: -HIV-U/High MUAC vs. HIV-U/Low MUAC at months 2, 3, and 6; -HIV-U/High MUAC vs. HIV-E/High
MUAC at months 2 and 3; -HIV-U/High MUAC vs. HIV-E/Low MUAC at each time points. Significant differences were observed for the following
length-for-age z-scores: -HIV-U/High MUAC vs. HIV-U/Low MUAC at month 6; -HIV-U/High MUAC vs. HIV-E/Low MUAC at months 3 and 6
Table 5 Multiple regression analysis of infant weight-for-age and length-for-age z-scores from birth to 6-months using mixed
models
Covariatea Weight-for-age z-score Length-for-age z-score
β P 95 % CI β P 95 % CI
Infant age, months -0.02 0.091 -0.05, 0.00 -0.13 <0.001 -0.18, -0.09
Infant is female -1.11 <0.001 -1.44, -0.79 -0.10 <0.001 -1.36, -0.63
Maternal parity -0.01 0.892 -0.10, 0.09 -0.08 0.141 -0.19, 0.03
Gestational mid-upper arm circumference, cm 0.11 <0.001 0.05, 0.17 0.11 0.001 0.05, 0.18
Mother was formally educated -0.12 0.629 -0.60, 0.36 -0.03 0.904 -0.57, 0.50
Mother is HIV-positive -0.65 <0.001 -1.00, -0.31 -0.49 0.012 -0.88, -0.11
Household has electricity 0.40 0.166 -0.17, 0.96 0.46 0.152 -0.17, 1.10
Exclusive breastfeeding durationb, wk -0.02 0.272 -0.06, 0.02 -0.02 0.358 -0.06, 0.02
Breastfeeding scorec 0.06 0.284 -0.05, 0.17 0.02 0.728 -0.10, 0.14
HIV human immunodeficiency virus
aMixed models include all covariates listed
bExclusive breastfeeding according to World Health Organization definition where no food or liquid other than prescribed medications, vitamins/minerals, or oral
rehydration fluids given
cA study-specific breastfeeding score was evaluated at each visit, and the individual visit scores were summed to provide an overall breastfeeding score. Infant
feeding practices were scored as: 0 = no breastfeeding; 1 = partial breastfeeding (defined as breast milk plus other foods and/or liquids); 2 = predominant
breastfeeding (defined as breast milk plus locally-prepared non-prescription anti-colic/anti-gripe water); 3 = exclusive breastfeeding. The overall breastfeeding
score summarized infant feeding practices over the one to 6-month period, with scores ranging from 0 to 12. In this cohort, the mean breastfeeding score
(±standard deviation) was 6.7 ± 2.3
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with poorer birth and infant growth outcomes; however,
further research is needed to define population and
disease-specific gestational MUAC reference values. Sub-
Saharan African and Asian studies have reported associa-
tions with MUAC cutoffs of 22 to 27.6 cm and adverse
pregnancy outcomes (LBW, intrauterine growth restric-
tion, preterm delivery) [10, 26–32]. In supplementary feed-
ing programs, 18.5 to 23 cm has been used to identify
pregnant women for eligibility [10]. Wasting was defined
as <22 cm in a large urban-based mixed-HIV status cohort
of pregnant Tanzanians (n = 13,760), and found to be more
prevalent among HIV-positive women [33]. Since these
data were from the pre-ART era, it is difficult to make dir-
ect comparisons with more recent studies.
Since many women in a rural and semi-rural setting
may never attend an antenatal clinic, POCT with gesta-
tional MUAC may be possible to roll-out even at the
village level. In addition, many women attend only a sin-
gle antenatal visit and deliver at home and this suggests
that interventions to prevent negative fetal and infant
consequences should begin during pregnancy and per-
haps a gestational MUAC cut-off on the more conserva-
tive upper end is needed. While identification of higher
risk pregnancies is a key step in improving fetal and in-
fant care, an ongoing challenge remains in selecting and
implementing the most appropriate interventions for
these women.
While maternal HIV care continues to improve and
important reductions in maternal HIV transmission have
been achieved in sub-Saharan Africa, the findings of this
study suggest that HIV-exposed, uninfected infants liv-
ing in this setting still have poorer growth outcomes
compared to HIV-unexposed infants. This study was not
designed to investigate the impact of ART on growth
among HIV-exposed infants and nevirapine adherence
was not ascertained. Further research is needed to
understand the dual impact of maternal HIV and in
utero ART-exposure according to various ART regimens
on infant growth outcomes. In this cohort, maternal
HIV-seropositivity was associated with reduced birth
weight and poorer infant growth through 6-months in
adjusted analyses. These findings are important to con-
sider since standard antenatal screening performed at
this clinic would be unlikely to identify HIV-positive
women as being at greater nutritional risk based on mean
anthropometric measurements, a finding similar to urban
cohorts in Tanzania [33] and Zimbabwe [34]. The birth
weight data from this study are consistent with a range of
findings from this region [35–37], and also contributes evi-
dence that maternal HIV status is a risk factor for shorter
birth length in rural and semi-rural Tanzania. Furthermore,
longitudinal data indicate HIV-exposed infants continued
to experience less favorable growth anthropometrics as has
been observed in other sub-Saharan African cohorts [38],
although these findings are not universal [17, 18, 39]. Differ-
ences in growth trajectories may be linked to urban-rural
differences and a variety of biological and social factors in-
cluding suboptimal infant feeding practices and maternal
illness or death. It is notable that in the present study, HIV-
positive mothers exclusively breastfed for a significantly lon-
ger duration than HIV-negative mothers and this may
partially explain the counterintuitive direction of association
between exclusive breastfeeding and infant growth. None-
theless, the average duration of exclusive breastfeeding in
both groups was far shorter than the WHO-recommended
6 months, and comparison to other studies is difficult since
the term “exclusive breastfeeding” is not universally defined
and evaluated in the same manner.
People living in rural and semi-rural areas account for
a substantial proportion of the population in many sub-
Saharan African countries, but conducting research in
these settings has noteworthy challenges. The proportion
of preterm deliveries observed in this study was high
(approximately 30 %) and although comparable with
other Tanzanian reports [40, 41], inaccuracies in gesta-
tional age estimation without ultrasound technology
may have resulted in misclassification as health workers
must instead rely on unreliable methods such as patient
recall of last menstruation and fundal height [42]. Dur-
ing the course of this study, Kisesa Health Centre faced
chronic and variable healthcare supply shortages. This
may have deterred women from traveling to the clinic to
receive antenatal and infant care, and limits the
generalizability of these findings to women willing and
able to attend clinic visits. It should also be noted that
pregnant women in this study were only tested for HIV
once, as part of standard antenatal care at the host
clinic, and it is possible that some HIV-negative women
may have seroconverted after being tested.
As is common in rural Africa, some participants were
difficult to contact without traceable addresses or tele-
phone numbers. To minimize attrition, participants con-
sented to home visits by a study team member if they
missed an appointment, a strategy that proved invaluable
in minimizing losses to follow-up. Finally, despite provision
of incidental clinic delivery costs and transportation to
women who chose to deliver at this antenatal clinic,
complete birth anthropometric data within 72 h were
unavailable for 24 % of infants - a proportion that
represents a study success given that approximately
50 % of births typically occur at a place other than a
health facility in this region [11].
Conclusions
Low infant birth weight is an important risk factor for early
infancy morbidity and mortality [2], making prevention of
fetal and infant growth impairment a key goal. Gestational
MUAC was able to identify women whose infants
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experienced poorer birth and growth anthropometrics.
While identifying at-risk mothers is only the first step to-
wards improving pregnancy and infant outcomes, evalu-
ation of gestational MUAC as a POCT and establishing
appropriate reference values is needed. Maternal health
based on standard clinical (e.g. Hb concentration) and ges-
tational anthropometric indicators did not differ according
to maternal HIV status; however, HIV-exposed, uninfected
infants still fared worse in this rural and semi-rural setting
and maternal HIV-seropositivity alone remains was a risk
factor for poorer fetal and infant growth.
Abbreviations
ANOVA: Analysis of variance; ART: Antiretroviral; BMI: Body mass index;
CI: Confidence interval; Hb: Hemoglobin; HIV: Human immunodeficiency
infection; LAZ: Length-for-age z-scores; LBW: Low birth weight; MUAC:
Mid-upper arm circumference; PMTCT: Prevention of mother to child
transmission; POCT: Point-of-care testing; SD: Standard deviation; TSF: Triceps
skinfold thickness; WAZ: Weight-for-age z-scores; WHO: World Health
Organization.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
Conceived and designed this research: ALW and JMM. Collected the data
used in this analysis: ALW and SHP. Provided study oversight: MU, DM, SK, JT,
JC and JMM. Analyzed the data: ALW. Wrote the paper: ALW. All authors
have read and approved the final draft.
Acknowledgements
We express our gratitude to the mothers and infants in this cohort, the staff
of the National Institute for Medical Research in Mwanza, Tanzania, and the
many individuals at health dispensaries and Kisesa Health Centre involved in
the research and care of women and children in Magu District. Funding was
provided by Mario Einaudi International Centre (to ALW) and funders had no
additional involvement.
Author details
1Division of Nutritional Sciences, Cornell University, Ithaca, NY, USA. 2National
Institute for Medical Research, Mwanza Research Centre, Mwanza, Tanzania.
3Department of Population Health, London School of Hygiene & Tropical
Medicine, London, UK. 4Present affiliation: Division of Infectious Diseases &
International Health, Department of Medicine, School of Medicine, University
of Virginia, Charlottesville, VA, USA.
Received: 13 November 2014 Accepted: 23 October 2015
References
1. Kramer MS. Intrauterine growth and gestational duration determinants.
Pediatrics. 1987;80(4):502–11.
2. McCormick MC. The contribution of low birth weight to infant mortality
and childhood morbidity. N Engl J Med. 1985;312(2):82–90.
3. World Health Organization. Maternal anthropometry and pregnancy
outcomes. A WHO Collaborative Study. Bull World Health Organ. 1995, 73
Suppl:1-98.
4. Villar J, Ba'aqeel H, Piaggio G, Lumbiganon P, Belizán JM, Farnot U, et al.
WHO antenatal care randomised trial for the evaluation of a new model of
routine antenatal care. Lancet. 2001;357(9268):1551–64.
5. Magoma M, Requejo J, Merialdi M, Campbell OM, Cousens S, Filippi V. How
much time is available for antenatal care consultations? Assessment of the
quality of care in rural Tanzania. BMC Pregnancy Childbirth. 2011;11:64.
doi: 10.1186/1471-2393-11-64.
6. Tang A, Dong K, Deitchler M, Chung M, Maalouf-Manasseh Z, Tumilowicz A,
et al. Use of cutoffs for mid-upper arm circumference (MUAC) as an
indicator or predictor of nutritional and health-related outcomes in
adolescents and adults: A systematic review. Food and Nutrition Technical
Assistance III Project (FANTA) Washington, DC: United States Agency for
International Development (USAID); 2013. p. 1–39.
7. Velzeboer MI, Selwyn BJ, Sargent F, Pollitt E, Delgado H. Evaluation of arm
circumference as a public health index of protein energy malnutrition in
early childhood. J Trop Pediatr. 1983;29(3):135–44.
8. Vijayaraghavan K, Sastry JG. The efficacy of arm circumference as a
substitute for weight in assessment of protein-calorie malnutrition. Ann
Hum Biol. 1976;3(3):229–33.
9. Ministry of Health. Guidelines on Maternal Nutrition in Uganda. 2010.
10. Ververs MT, Antierens A, Sackl A, Staderini N, Captier V. Which
anthropometric indicators identify a pregnant woman as acutely
malnourished and predict adverse birth outcomes in the humanitarian
context? PLoS Currents. 2013, 5.
11. National Bureau of Statistics. Tanzania Demographic and Health Survey
2010. National Bureau of Statistics (Tanzania) and ICF Macro 2011.
12. World Health Organization. Antiretroviral drugs for treating pregnant
women and preventing HIV infection in infants: towards universal access,
July 2010. 2010.
13. Massawe SN, Urassa EN, Nystrom L, Lindmark G. Effectiveness of primary
level antenatal care in decreasing anemia at term in Tanzania. Acta Obstet
Gynecol Scand. 1999;78(7):573–9.
14. World Health Organization. Indicators for assessing infant and young child
feeding practices: part 1: definitions: conclusions of a consensus meeting
held 6-8 November 2007 in Washington DC, USA. 2008.
15. Thame M, Wilks RJ, McFarlane-Anderson N, Bennett FI, Forrester TE.
Relationship between maternal nutritional status and infant’s weight and
body proportions at birth. Eur J Clin Nutr. 1997;51(3):134–8.
16. Kramer MS. Determinants of low birth weight: methodological assessment
and meta-analysis. Bull World Health Organ. 1987;65(5):663.
17. Bailey RC, Kamenga MC, Nsuami MJ, Nieburg P, St Louis ME. Growth of
children according to maternal and child HIV, immunological and disease
characteristics: a prospective cohort study in Kinshasa, Democratic Republic
of Congo. Int J Epidemiol. 1999;28(3):532–40.
18. Lepage P, Msellati P, Hitimana D-G, Bazubagira A, VAN GOETHEM C,
Simonon A, et al. Growth of human immunodeficiency type 1-infected and
uninfected children: a prospective cohort study in Kigali, Rwanda, 1988 to
1993. Pediatr Infect Dis J. 1996;15(6):479–85.
19. Filteau S. The HIV‐exposed, uninfected african child. Trop Med Int Health.
2009;14(3):276–87.
20. Isanaka S, Duggan C, Fawzi WW. Patterns of postnatal growth in HIV-
infected and HIV-exposed children. Nutr Rev. 2009;67(6):343–59.
21. Ramlal RT, Tembo M, Soko A, Chigwenembe M, Ellington S, Kayira D, et al.
Maternal mid–upper arm circumference is associated with birth weight
among HIV-infected malawians. Nutr Clin Pract. 2012;27(3):416–21.
22. Villamor E, Dreyfuss ML, Baylin A, Msamanga G, Fawzi WW. Weight loss
during pregnancy is associated with adverse pregnancy outcomes among
HIV-1 infected women. J Nutr. 2004;134(6):1424–31.
23. Weigl BH, Neogi T, McGuire H. Point-of-care diagnostics in low-resource
settings and their impact on care in the age of the noncommunicable and
chronic disease epidemic. J Lab Automation. 2013:2211068213515246.
24. Peeling R, Mabey D. Point‐of‐care tests for diagnosing infections in the
developing world. Clin Microbiol Infect. 2010;16(8):1062–9.
25. Kettler H, White K, Hawkes S. Mapping the landscape of diagnostics for
sexually transmitted infections: key findings and recommendations.
Mapping the landscape of diagnostics for sexually transmitted infections:
key findings and recommendations 2004.
26. Karim E, Mascie-Taylor CG. The association between birthweight,
sociodemographic variables and maternal anthropometry in an urban
sample from Dhaka, Bangladesh. Ann Hum Biol. 1997;24(5):387–401.
27. Verhoeff FH, Brabin BJ, van Buuren S, Chimsuku L, Kazembe P, Wit JM, et al.
An analysis of intra-uterine growth retardation in rural Malawi. Eur J Clin
Nutr. 2001;55(8):682–9.
28. Mohanty C, Prasad R, Srikanth Reddy A, Ghosh JK, Singh TB, Das BK.
Maternal anthropometry as predictors of low birth weight. J Trop Pediatr.
2006;52(1):24–9.
29. Rollins NC, Coovadia HM, Bland RM, Coutsoudis A, Bennish ML, Patel D,
et al. Pregnancy outcomes in HIV-infected and uninfected women in rural
and urban South Africa. J Acquir Immune Defic Syndr. 2007, 44(3):321-328
310.1097/QAI.1090b1013e31802ea31804b31800.
30. Ojha N, Malla DS. Low birth weight at term: relationship with maternal
anthropometry. JNMA J Nepal Med Assoc. 2007;46(166):52–6.
Wilkinson et al. BMC Pregnancy and Childbirth  (2015) 15:277 Page 12 of 13
31. Sebayang SK, Dibley MJ, Kelly PJ, Shankar AV, Shankar AH. Determinants of
low birthweight, small-for-gestational-age and preterm birth in Lombok,
Indonesia: analyses of the birthweight cohort of the SUMMIT trial. Trop Med
Int Health. 2012;17(8):938–50.
32. Assefa N, Berhane Y, Worku A. Wealth status, mid upper arm circumference
(MUAC) and antenatal care (ANC) are determinants for low birth weight in
Kersa, Ethiopia. PLoS One. 2012;7(6):29.
33. Villamor E, Msamanga G, Spiegelman D, Coley J, Hunter DJ, Peterson KE,
et al. HIV status and sociodemographic correlates of maternal body size and
wasting during pregnancy. Eur J Clin Nutr. 2002;56(5):415–24.
34. Friis H, Gomo E, Nyazema N, Ndhlovu P, Kaestel P, Krarup H, et al. HIV-1 viral
load and elevated serum alpha(1)-antichymotrypsin are independent
predictors of body composition in pregnant Zimbabwean women. J Nutr.
2002;132(12):3747–53.
35. Ayisi JG, van Eijk AM, ter Kuile FO, Kolczak MS, Otieno JA, Misore AO, et al.
The effect of dual infection with HIV and malaria on pregnancy outcome in
western Kenya. AIDS. 2003;17(4):585–94.
36. Braddick MR, Kreiss JK, Embree JB, Datta P, Ndinya-Achola JO, Pamba H,
et al. Impact of maternal HIV infection on obstetrical and early neonatal
outcome. AIDS. 1990;4(10):1001–5.
37. Mmiro F, Ndugwa C, Guay L, Hom D, Ball P, Mugisha N, et al. Effect of
human immunodeficiency virus-1 infection on the outcome of pregnancy
in Ugandan women. Pediatr AIDS HIV Infect. 1993;4(2):67–73.
38. Makasa M, Kasonka L, Chisenga M, Sinkala M, Chintu C, Tomkins A, et al.
Early growth of infants of HIV-infected and uninfected Zambian women.
Trop Med Int Health. 2007;12(5):594–602.
39. Newell ML, Borja MC, Peckham C. Height, weight, and growth in children
born to mothers with HIV-1 infection in Europe. Pediatrics. 2003;111(1):e52–60.
40. D'Cruz R, Harding K. Investigating risk factors for preterm birth in rural
Tanzania: a case-control study. Arch Dis Child Fetal Neonatal Ed. 2012;97
Suppl 1:A112–2.
41. Fawzi WW, Msamanga GI, Spiegelman D, Urassa EJ, McGrath N, Mwakagile
D, et al. Randomised trial of effects of vitamin supplements on pregnancy
outcomes and T cell counts in HIV-1-infected women in Tanzania. Lancet.
1998;351(9114):1477–82.
42. Beazley JM, Underhill RA. Fallacy of the fundal height. Br Med J.
1970;4(5732):404–6.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Wilkinson et al. BMC Pregnancy and Childbirth  (2015) 15:277 Page 13 of 13
